In an attempt to find out how prevalent the use of the hallucinogenic chemicals is in Maryland, authorities from state’s Department of Health and Mental Hygiene have initiated a month-long probe which could lead to state-wide ban on the sale or possession of synthetic stimulant drugs which are being marketed as ‘bath salts.’

Taking the total number of bank failures to 26, regulators closed down banks in Maryland, Illinois, Florida and Utah, a development which has put increased pressure on the Federal Deposit Insurance Corp. to rapidly try and dispose off the mounting toxic assets.

After employing the use of 3-D ultrasound measures, scientists and researchers from the University of Maryland and Yale University have managed to determine that measuring the fetal zone of the adrenal glands is a much better predictor of premature birth, as compared to measuring the cervical length, which is the general way.

On Wednesday, Jos. A. Bank Clothiers Inc. delighted investors by posting a whopping 26% rise in earnings for the current fiscal year's third quarter, making this the 14th consecutive quarter for which the company has reported a successful rise in profits. According to the firm, the biggest improvement was recorded by sales of men's products.

A $2 million new equity financing has been recently closed by Pixelligent Technologies LLC, the award-winning development stage nanotechnology company. The company, with the University of Maryland’s incubator building as its headquarters, intends using the new funding for boosting existing and impending development of nanotechnology applications.

As a result of the government’s “stress test” of the Atlanta-based SunTrust Banks Inc, – which required the bank to look for $2.2 billion of new equity capital – the bank Friday announced its move of cutting its dividend by 90 percent and selling nearly $1.25 billion of its common stock.

With the Food and Drug Administration (FDA) approving Vanda Pharmaceuticals' earlier-rejected schizophrenia drug - Fanapt (iloperidone) - a whopping eight-fold increase, a 643 percent jump, in the shares of the Rockville, Maryland-based drugmaker was nothing short of astonishing!

Shares of drug developer Human Genome Sciences Inc. plummeted to nearly half Monday as the company’s results for the developing hepatitis C drug Albuferon in a late-stage trial, failed to show numerically better efficacy compared to standard-of-care.

The deciphering of the genetic code of the omnipresent common cold virus - rhinovirus - by the researchers at the University of Maryland and the University of Wisconsin indicates the newest step in the direction of finding an effective cure for cold.

According to the findings of Maryland’s National Cancer Institute, the excessive presence of certain ‘B cells’, called monoclonal B cells, in the blood could well be an early warning sign of the most commonly-occurring leukemia, CLL - chronic lymphocytic leukemia.